ASHLEY FLATTERY: Open Payments
NPI 1639462708 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 25 payments from 10 companies in 2025. Trend: 2023 $366 · 2024 $309 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $162 |
| GENZYME CORPORATION | 4 | $71 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Insulet Corporation | 1 | $45 |
| GlaxoSmithKline, LLC. | 3 | $42 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Optinose US, Inc. | 1 | $19 |
| ALK-Abello, Inc | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: DUPIXENT, Xhance, OMNIPOD, NUCALA, NEFFY, TEZSPIRE, PRE-PEN, XOLAIR.
Industry payments across IA — which companies pay providers there.
